Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Acute Treatment
What is the purpose of this trial?
This study will test the effectiveness and relative efficacy of behavioral and pharmacologic treatments, alone and in combination, for the treatment of binge eating disorder (BED) in patients with obesity. This is an acute treatment comparing behavioral weight loss alone or in combination with naltrexone/bupropion medication.
- Trial withNational Institute of Diabetes and Digestive & Kidney Diseases (NIDDK)
- Ages18 years - 70 years
- Last Updated07/10/2023
- Study HIC#2000021769